J&J prostate cancer drug reduces risk of cancer spread and death in late-stage study
IAEA reports drone strike damage at Zaporizhzhia nuclear plant
ZenaTech: I Like The Story, But Not The Numbers
J&J’s apalutamide cuts prostate cancer death risk by 20%
This article was written by Follow Wail Shudar, M.S., is a quantitative investor and AI professional with over a decade of experience in the technology sector....
Jobs report on tap for soaring US stocks as rate path, bond yields eyed as risks
India’s primary market is set for an active week in the mainboard segment, with two public issues scheduled to open for subscription even as investor sentiment...
Saudi Arabia stocks higher at close of trade; Tadawul All Share up 0.46%
Intellia Therapeutics – Steady Progress, Historic Commercial Approval In Sight
Piotr Swat | Lightrocket | Getty Images An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a...